Europe Immunochemistry Market to Reach US$ 775.97 Mn at a CAGR of 6.9% in 2027

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Immunochemistry Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Immunochemistry Market – Key Market Dynamics

5.1 Growth Drivers

5.2 Market Opportunities

5.3 Future Trends

5.4 Impact of Drivers and Restraints

6. Europe Immunochemistry Market Regional Analysis

6.1 Europe Immunochemistry Market Overview

6.2 Europe Immunochemistry Market Revenue 2016-2027 (US$ Million)

6.3 Europe Immunochemistry Market Forecast Analysis

7. Europe Immunochemistry Market Analysis – by Application

7.1 Diagnostics

7.1.1 Overview
7.1.2 Diagnostics: Europe Immunochemistry Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Drug Testing

7.2.1 Overview
7.2.2 Drug Testing: Europe Immunochemistry Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Immunochemistry Market Analysis – by Product

8.1 Antibodies

8.1.1 Overview
8.1.2 Antibodies: Europe Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Equipment

8.2.1 Overview
8.2.2 Equipment: Europe Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)

8.3 Reagents

8.3.1 Overview
8.3.2 Reagents: Europe Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Kits

8.4.1 Overview
8.4.2 Kits: Europe Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)

9. Europe Immunochemistry Market Analysis – by End User

9.1 Hospitals and Diagnostic Laboratories

9.1.1 Overview
9.1.2 Kits: Europe Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Research Institutes

9.2.1 Overview
9.2.2 Kits: Europe Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)

10. Europe Immunochemistry Market – Europe Analysis

10.1 Europe

10.1.1 Europe Immunochemistry Market Breakdown, by Key Country, 2019 and 2027 (%)
10.1.1.1 Europe Immunochemistry Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 UK: Europe Immunochemistry Market Breakdown, by Application
10.1.1.1.2 UK: Europe Immunochemistry Market Breakdown, by Product
10.1.1.1.3 UK: Europe Immunochemistry Market Breakdown, by End User

10.1.1.2 Germany: Europe Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 Germany: Europe Immunochemistry Market Breakdown, by Application
10.1.1.2.2 Germany: Europe Immunochemistry Market Breakdown, by Product
10.1.1.2.3 Germany: Europe Immunochemistry Market Breakdown, by End User

10.1.1.3 France: Europe Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 France: Europe Immunochemistry Market Breakdown, by Application
10.1.1.3.2 France: Europe Immunochemistry Market Breakdown, by Product
10.1.1.3.3 France: Europe Immunochemistry Market Breakdown, by End User

10.1.1.4 Russia: Europe Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.4.1 Russia: Europe Immunochemistry Market Breakdown, by Application
10.1.1.4.2 Russia: Europe Immunochemistry Market Breakdown, by Product
10.1.1.4.3 Russia: Europe Immunochemistry Market Breakdown, by End User

10.1.1.5 Italy: Europe Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.5.1 Italy: Europe Immunochemistry Market Breakdown, by Application
10.1.1.5.2 Italy: Europe Immunochemistry Market Breakdown, by Product
10.1.1.5.3 Italy: Europe Immunochemistry Market Breakdown, by End User

10.1.1.6 Rest of Europe: Europe Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Immunochemistry Market Breakdown, by Application
10.1.1.6.2 Rest of Europe: Europe Immunochemistry Market Breakdown, by Product
10.1.1.6.3 Rest of Europe: Europe Immunochemistry Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Immunochemistry Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 PerkinElmer, Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Abcam Plc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Agilent Technologies,

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Bio SB

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Bio-Rad Laboratories, Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Cell Signalling Technology, Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 F. Hoffmann-La Roche Ltd.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Danaher

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Merck KGaA

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Thermo Fisher Scientific, Inc.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights